Suppression of apolipoprotein AI gene expression in HepG2 cells by TNF α and IL-1β

Biochimica et Biophysica Acta - General Subjects

Volumn 1623, Issue 2-3, 2003, Pages 120-128

  Haas, Michael J ^a   Horani, Mohammad ^a   Mreyoud, Amjad ^a   Plummer, Brian ^a   Wong, Norman C W ^b   Mooradian, Arshag D ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Apolipoprotein AI; IL 1 ; Insulin resistance; TNF

Indexed keywords

APOLIPOPROTEIN A1; CHLORAMPHENICOL ACETYLTRANSFERASE; CIS ACTING ELEMENT; INTERLEUKIN 1BETA; MESSENGER RNA; NUCLEAR FACTOR; NUCLEOTIDE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; CYTOKINE RESPONSIVE ELEMENT; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; GENE CONSTRUCT; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE MAPPING; GENE REPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INSULIN RESISTANCE; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN SECRETION; REPORTER GENE; STATISTICAL SIGNIFICANCE; TRANSCRIPTION INITIATION SITE;

FELIS CATUS;

EID: 0142169363     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2003.08.004     Document Type: Article

References (58)

1. Hotamisligil G.S. The role of TNF α and TNF receptors in obesity and insulin resistance. J. Intern. Med. 245:1999;621-625.
2. Le Roith D., Zick Y. Recent advances in our understanding of insulin action and insulin resistance. Diabetes Care. 24:2001;588-597.
3. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science. 259:1993;87-91.
4. Hotamisligil G.S., Arner P., Caro J.F., Atkinson R.L., Speigelman B.M. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J. Clin. Invest. 95:1995;2409-2915.
5. Sykiotis G.P., Papavassiliou A.G. Serine phosphorylation of insulin receptor substrate-1: a novel target for the reversal of insulin resistance. Mol. Endocrinol. 15(1):2001;864-1869.
6. Uysal K.T., Wiesbrock S.M., Marino M.W., Hotamisligil G.S. Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature. 389:1997;610-614.
7. Ventre J., Doebber T., Wu M., MacNaul K., Stevens K., Pasparakis M., Kollias G., Moller D.E. Targeted disruption of the tumor necrosis factor-α gene: metabolic consequences in obese and nonobese mice. Diabetes. 46:1997;1526-1531.
8. Hardardottie I., Moser A.H., Memon R., Grunfeld C., Feingold K.R. Effects of TNF, IL-1, and the combination of both cytokines on cholesterol metabolism in Syrian hamsters. Lymphokine Cytokine Res. 13:1994;161-166.
9. Ettinger W.H., Varma V.K., Sorci-Thomas M., Parks J.S., Sigmon R.C., Smith T.K., Verdery R.B. Cytokines decrease apolipoprotein accumulation in medium from HepG2 cells. Arterioscler. Thromb. 14:1994;8-13.
10. Song H., Saito K., Fujigaki S., Noma A., Ishiguro H., Nagatsu T., Seishima M. IL-1β and TNF-α suppress apolipoprotein (apo) E secretion and apo A-I expression in HepG2 cells. Cytokine. 10:1998;275-280.
11. Senn J.J., Klover P.J., Nowak I.A., Mooney R.A. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes. 51:2002;3391-3399.
12. Murao K., Wada Y., Nakamura T., Taylor A.H., Mooradian A.D., Wong N.C.W. Effects of glucose and insulin on rat apolipoprotein A-I gene expression. J. Biol. Chem. 273:1998;18959-18965.
13. Lam J.K., Matsubara S., Mihara K., Zheng X.L., Mooradian A.D., Wong N.C. Insulin induction of apolipoprotein AI, role of Sp1. Biochemistry. 42:2003;2680-2690.
14. Hargrove G.M., Junco A., Wong N.C. Hormonal regulation of apolipoprotein AI. J. Mol. Endocrinol. 22:1999;103-111.
15. Denson L.A., Menon R.K., Shaufl A., Bajwa H.S., Williams C.R., Karpen S.J. TNF-α downregulates murine hepatic growth hormone receptor expression by inhibiting Sp1 and Sp3 binding. J. Clin. Invest. 107:2001;1451-1458.
16. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
17. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Proc. Natl. Acad. Sci. U. S. A. 76:1979;4350-4354.
18. Oakley B.R., Kirsch D.R., Morris N.R. A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels. Anal. Biochem. 105:1980;361-363.
19. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 132:1987;6-13.
20. Lehrach H., Diamond D., Wozney J.M., Boedtker H. RNA molecular weight determinations by gel electrophoresis under denaturing conditions: a critical reexamination. Biochemistry. 16:1977;4743-4751.
21. Feinberg A.P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific-activity. Anal. Biochem. 132:1983;6-13.
22. Taylor A.H., Wishart P., Lawless D.E., Raymond J., Wong N.C.W. Identification of functional positive and negative thyroid hormone-responsive elements in the rat apolipoprotein promoter. Biochemistry. 35:1996;8281-8288.
23. Murao K., Bassyouni H., Taylor A.H., Wanke I.E., Wong N.C. Hepatocyte nuclear factor 4 inhibits the activity of site A from the rat apolipoprotein AI gene. Biochemistry. 36:1997;301-306.
24. Haas M.J., Reinacher D., Li J.-P., Wong N.C.W., Mooradian A.D. Regulation of apoA1 gene expression with acidosis: requirement for a transcriptional repressor. J. Mol. Endocrinol. 27:2001;43-57.
25. Gorman C.M., Moffat L.F., Howard B.H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1982;1044-1051.
26. Herbomel P., Bourachot B., Yaniv M. Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma. Cell. 39:1984;653-662.
27. Cox G.S., Gutkin D.W., Haas M.J., Cosgrove D.E. Isolation of an Alu repetitive DNA binding protein and effect of CpG methylation on binding to its recognition sequence. Biochim. Biophys. Acta. 1396:1998;67-87.
28. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
29. Higuchi K., Law S.W., Hoeg J.M., Schumacher U.K., Meglin N., Brewer H.B. Jr. Tissue-specific expression of apolipoprotein A-I (ApoA-I) is regulated by the 5′-flanking region of the human apoA-I gene. J. Biol. Chem. 263:1988;18530-18536.
30. Sastry K.N., Seedorf U., Karathanasis S.K. Different cis-acting DNA elements control expression of the human apolipoprotein AI gene in different cell types. Mol. Cell. Biol. 8:1988;605-614.
31. Widom R.L., Ladias J.A.A., Kouidou S., Karathanasis S.K. Synergistic interactions between transcription factors control expression of the apolipoprotein AI gene in liver cells. Mol. Cell. Biol. 11:1991;677-687.
32. Spranger J., Kroke A., Mohlig M., Hoffmann K., Bergmann M.M., Ristow M., Boeing H., Pfeiffer A.F. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC) - Potsdam Study. Diabetes. 52:2003;812-817.
33. Ladias J.A.A., Karathanasis S.K. Regulation of the apolipoprotein AI gene by ARP-1, a novel member of the steroid receptor superfamily. Science. 251:1991;561-565.
34. Ge R., Rhee M., Malik S., Karathanasis S.K. Transcriptional repression of apolipoprotein AI gene expression by orphan receptor ARP-1. J. Biol. Chem. 269:1994;13185-13192.
35. Hardon E.M., Frain M., Paonessa G., Cortese R. Two distinct factors interact with the promoter regions of several liver-specific genes. EMBO J. 7:1988;1711-1719.
36. Vu-Dac N., Schoonjans K., Laine B., Fruchart J.-C., Auwerx J., Staels B. Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element. J. Biol. Chem. 269:1994;31012-31018.
37. Staels B., Dallongeville J., Auwerx J., Schoonjans K., Leitersdorf E., Fruchart J.-C. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation. 98:1998;2088-2093.
38. Giller T., Hennes U., Kempen H.J. Regulation of human apolipoprotein A-I expression in Caco-2 and HepG2 cells by all-trans and 9-cis retinoic acids. J. Lipid Res. 36:1995;1021-1028.
39. Widom R.L., Rhee M., Karathanasis S.K. Repression by ARP-1 sensitizes apolipoprotein AI gene responsiveness to RXRα and retinoic acid. Mol. Cell. Biol. 12:1992;3380-3389.
40. Harnish D.C., Malik S., Kilbourne E., Costa R., Karathanasis S.K. Control of apolipoprotein AI gene expression through synergistic interactions between hepatocyte nuclear factors 3 and 4. J. Biol. Chem. 271:1996;13621-13628.
41. Harnish D.C., Malik S., Karathanasis S.K. Activation of apolipoprotein AI gene transcription by the liver enriched factor HNF-3. J. Biol. Chem. 269:1994;28220-28226.
42. de The H., Marchio A., Tiollais P., Dejean A. Differential expression and ligand regulation of the retinoic acid receptor α and β genes. EMBO J. 8:1989;429-433.
43. Rottman J.N., Widom R.L., Nadal-Ginard B., Mahdavi V., Karathanasis S.K. A retinoic acid response element in the apolipoprotein AI gene distinguishes between two different retinoic acid response pathways. Mol. Cell. Biol. 11:1991;3814-3820.
44. Vu-Dac N., Chopin-Delannoy S., Gervois P., Bonnelye E., Martin G., Fruchar J.-C., Laudet V., Staels B. The nuclear receptors peroxisome proliferator-activated receptors α and Rev-erbα mediate the species-species regulation of apolipoprotein A-I expression by fibrates. J. Biol. Chem. 273:1998;25713-25720.
45. Lamb P., McKnight S.L. Diversity and specificity in transcriptional regulation: the benefits of heterotypic dimerization. Trends Biochem. Sci. 16:1991;417-422.
46. 3 signaling. Nature. 355:1992;446-449.
47. Ruan H., Miles P.D.G., Ladd C.M., Ross K., Golub T.R., Olefsky J.M., Lodish H.F. Profiling gene transcription in vivo reveals adipose tissue as an immediate target of tumor necrosis factor-α: implications for insulin resistance. Diabetes. 51:2002;3176-3188.
48. Kilbourne E.J., Widom R., Harnish D.C., Malik S., Karathanasis S.K. Involvement of early growth response factor Egr-1 in apolipoprotein AI gene transcription. J. Biol. Chem. 270:1995;7004-7010.
49. Georgopoulos S., Kan H.Y., Reardon-Alulis C., Zannis V. The Sp1 sites of the human apoCIII enhancer are essential for the expression of the apoCIII gene and contribute to the hepatic and intestinal expression of the apoA-I gene in transgenic mice. Nucleic Acids Res. 28:2000;4919-4929.
50. Sanchez H.B., Yieh L., Osborne T.F. Cooperation by sterol regulatory element binding protein and Sp1 in sterol regulation of low density lipoprotein receptor gene. J. Biol. Chem. 270:1995;1161-1169.
51. Porter W., Saville B., Hoivik D., Safe D. Functional synergy between the transcription factor Sp1 and the estrogen receptor. Mol. Endocrinol. 11:1997;1569-1580.
52. Baud V., Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11:2001;372-377.
53. Stylianou E., Saklatvala J. Interleukin-1. Int. J. Biochem. Cell Biol. 30:1998;1075-1079.
54. Suzawa M., Takada I., Yanagisawa J., Ohtake F., Ogawa S., Yamauchi T., Kadowaki T., Takeuchi Y., Shibuya H., Gotoh Y., Matsumoto K., Kato S. Cytokines suppress adipogenesis and PPAR-gamma function through the TAK1/TAB1/NIK cascade. Nat. Cell Biol. 5:2003;224-230.
55. Teruel T., Hernandez R., Lorenzo M. Ceramide mediates insulin resistance by tumor necrosis factor-α in brown adipocytes by maintaining Akt in an inactive dephosphorylated state. Diabetes. 50:2001;2471-2563.
56. Mooradian A.D., Wong N.C.W., Shah G.N. Apolipoprotein A1 expression in young and aged rats is modulated by dietary carbohydrates. Metabolism. 46:1997;1132-1136.
57. Shah N.G., Wong N.C.W., Mooradian A.D. Age-related changes in apolipoprotein A-I expression. Biochim. Biophys. Acta. 1259:1995;277-282.
58. Malle E., Leonhard B., Knipping G., Sattler W. Effects of cytokines, butyrate and dexamethasone on serum amyloid A and apolipoprotein A-I synthesis in human HUH-7 hepatoma cells. Scand. J. Immunol. 50:1999;183-187.